KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Share-based Compensation (2016 - 2025)

Biogen has reported Share-based Compensation over the past 17 years, most recently at $59.6 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $59.6 million for Q4 2025, down 20.64% from a year ago — trailing twelve months through Dec 2025 was $290.8 million (changed 0.14% YoY), and the annual figure for FY2025 was $290.8 million, changed 0.14%.
  • Share-based Compensation for Q4 2025 was $59.6 million at Biogen, down from $75.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for BIIB hit a ceiling of $81.0 million in Q1 2025 and a floor of $54.1 million in Q2 2021.
  • Median Share-based Compensation over the past 5 years was $68.8 million (2021), compared with a mean of $66.9 million.
  • Biggest five-year swings in Share-based Compensation: soared 66.27% in 2021 and later decreased 20.64% in 2025.
  • Biogen's Share-based Compensation stood at $58.8 million in 2021, then grew by 14.29% to $67.2 million in 2022, then fell by 18.3% to $54.9 million in 2023, then soared by 36.79% to $75.1 million in 2024, then fell by 20.64% to $59.6 million in 2025.
  • The last three reported values for Share-based Compensation were $59.6 million (Q4 2025), $75.3 million (Q3 2025), and $74.9 million (Q2 2025) per Business Quant data.